End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients

被引:0
|
作者
Joseph Ahn
Taft Bhuket
Sasan Mosadeghi
Catherine Frenette
Benny Liu
Robert J. Wong
机构
[1] University of California,School of Medicine
[2] Alameda Health System-Highland Hospital,Endoscopy Unit, Division of Gastroenterology and Hepatology
[3] Scripps Green Hospital,Department of Organ Transplantation
来源
Hepatology International | 2016年 / 10卷
关键词
Liver transplantation; Liver failure; UNOS/OPTN; Status 1A; Waitlist survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:838 / 846
页数:8
相关论文
共 50 条
  • [21] The Model for End-stage Liver Disease (MELD)
    Kamath, Patrick S.
    Kim, W. Ray
    HEPATOLOGY, 2007, 45 (03) : 797 - 805
  • [22] Important predictor of mortality in patients with end-stage liver disease
    Kim, Hyung Joon
    Lee, Hyun Woong
    CLINICAL AND MOLECULAR HEPATOLOGY, 2013, 19 (02) : 105 - 115
  • [23] Impact of model for end-stage liver disease (MELD) score for mortality in patients undergoing coronary bypass surgery
    Dolapoglu, A.
    Avci, E.
    Argan, O.
    Safak, O.
    Gorcan, A.
    Akgun, D. E.
    Catalkaya, S.
    Kiris, R.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2021, 122 (02): : 125 - 131
  • [24] Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End-Stage Liver Disease Patients
    Ross, K.
    Patzer, R. E.
    Goldberg, D. S.
    Lynch, R. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (11) : 2879 - 2889
  • [25] A Failure of the Model of End-stage Liver Disease (MELD) - Significant Mortality among Cirrhotic Patients with a Low (<20) MELD Score
    Ladner, Daniela
    Skibba, Kathryn
    Jackson, Kathryn
    Safaeinili, Niloufar
    Goldberg, David S.
    VanWagner, Lisa B.
    Goel, Satyender
    Kho, Abel
    Daud, Amna
    Salehitezangi, Nazanin
    Skaro, Anton I.
    HEPATOLOGY, 2015, 62 : 630A - 631A
  • [26] Comparison of Mortality Prediction Between the Model for End-Stage Liver Disease-3.0 (MELD-3.0) and the Model for End-Stage Liver Disease-Lactate (MELD-La) in Korean Patients with Liver Cirrhosis
    Yoo, Seung-Kang
    Kim, Jeong-Han
    Choe, Won-Hyeok
    Kwon, So-Young
    MEDICINA-LITHUANIA, 2025, 61 (03):
  • [27] Model for End-Stage Liver Disease (MELD) predicts survival in patients with variceal bleeding
    Bambha, KM
    Van Ijperen, M
    Malinchoc, M
    Kremers, WK
    Kim, RW
    Wiesner, RH
    Kamath, PS
    GASTROENTEROLOGY, 2003, 124 (04) : A665 - A665
  • [28] Model for End-Stage Liver Disease (MELD) predicts survival in patients with variceal bleeding
    van Ijperen, M
    Bambha, KM
    Malinchoc, M
    Kremers, WK
    Kim, WR
    Wiesner, RH
    Kamath, PS
    JOURNAL OF HEPATOLOGY, 2003, 38 : 73 - 73
  • [29] Lean Patients with Non-alcoholic Fatty Liver Disease Have a Higher Frequency of Cirrhosis and Higher Model for End-Stage Liver Disease Scores Compared to Non-lean Patients
    Young, Steven
    Mansour, William
    Hoppmann, Nicholas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S355 - S355
  • [30] Outcomes After Liver Transplantation in Patients Achieving a Model for End-Stage Liver Disease Score of 40 or Higher
    Alexopoulos, Sophoclis
    Matsuoka, Lea
    Cho, Yong
    Thomas, Elizabeth
    Sheikh, Mohd
    Stapfer, Maria
    Dhanireddy, Kiran
    Sher, Linda
    Selby, Rick
    Genyk, Yuri
    TRANSPLANTATION, 2013, 95 (03) : 507 - 512